Assignee
CLOVIS ONCOLOGY INC
US·2 granted patents·3 pending applications·3 citations·filing 2014–2018
Top patents by PatentIndex Score
5 records- 0185US9987285B2High dosage strength tablets of rucaparibCLOVIS ONCOLOGY INC·Filed 2015·Granted Jun 5, 2018·2 cites·28 claims
- 0282US10130636B2High dosage strength tablets of rucaparibCLOVIS ONCOLOGY INC·Filed 2018·Granted Nov 20, 2018·1 cites·11 claims
- 0355US2019099430A1High Dosage Strength Tablets of RucaparibCLOVIS ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 0440US2016074399A1Salts of an Epidermal Growth Factor Receptor Kinase InhibitorCLOVIS ONCOLOGY INC·Filed 2014·Application pending·0 cites
- 0538US2018163271A1Use of PARP Inhibitors to Treat Breast or Ovarian Cancer Patients Showing a Loss of HeterozygosityCLOVIS ONCOLOGY INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →